Moderna
MRNA
#414
Rank
NZ$104.11 B
Marketcap
NZ$260.79
Share price
9.50%
Change (1 day)
536.74%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

ESG Reports

Thumbnail Moderna
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Moderna
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report